Green Cross plant in Quebec

Green Cross Biotherapeutics (GCBT) CEO Kim Young-ho, third from left, poses with Montreal Mayor Denis Coderre, second from left, and Saint-Laurent Mayor Alan DeSousa, fourth from left, during the celebration of the completion of a plasma derivatives factory in Montreal, Quebec, Canada, Monday. Others present are Quebec Deputy Premier Dominique Anglade, second from right, and Quebec Health Minister Gaetan Barrette, right. The completion came 28 months after groundbreaking in October 2015. Green Cross Corp., Korea’s leading vaccine and plasma derivatives maker, invested 250 million Canadian dollars (220 billion won) in the GCBT plant to produce intravenous immunoglobulin and albumin beginning in 2020. The factory with an annual capacity of making 1 million liters of derivatives will serve as a production base for the North American market. / Courtesy of Green Cross Corp.